Related Experiment Video
Updated: Jan 17, 2026
09:14
Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
Published on: October 26, 2017
10.0K
From Cell Reprogramming to Tissue Rejuvenation: Countering Aging by Targeting a Gerozyme
Helen M Blau1, Ermelinda Porpiglia2
1Baxter Laboratory for Stem Cell Biology, Stanford University School of Medicine, Stanford, California, USA;
Annual Review of Pharmacology and Toxicology
|September 19, 2025
Summary
This research explores cell plasticity and stem cells, ultimately discovering 15-prostaglandin dehydrogenase (15-PGDH) as a key regulator of muscle aging. Inhibiting this gerozyme rejuvenates muscle tissue, offering potential treatments for muscle wasting.
Area of Science:
- Cellular Biology
- Aging Research
- Regenerative Medicine
Background:
- The specialized state of cells was long considered fixed and irreversible.
- Stem cells are critical for tissue repair and regeneration.
- Muscle wasting due to aging, disease, or disuse presents a significant health challenge.
Purpose of the Study:
- To investigate cell plasticity and the role of stem cells in tissue repair.
- To identify key regulators of the aging process in muscle tissue.
- To explore therapeutic strategies for combating muscle wasting.
Main Methods:
- Probing cell plasticity to challenge established cellular dogma.
- Investigating the function and potential of stem cells.
- Identifying and characterizing the gerozyme 15-prostaglandin dehydrogenase (15-PGDH).
- Utilizing small-molecule drugs to inhibit 15-PGDH activity in muscle tissue.
Main Results:
- Demonstrated that a cell's specialized state is not necessarily fixed.
- Highlighted the importance of stem cells in tissue repair mechanisms.
- Discovered 15-prostaglandin dehydrogenase (15-PGDH) as a master regulator of muscle aging.
- Showed that inhibiting 15-PGDH leads to muscle rejuvenation and strengthening.
Conclusions:
- The discovery of 15-PGDH offers a novel target for therapeutic intervention in aging and muscle wasting.
- Inhibiting 15-PGDH presents a promising strategy for developing treatments for debilitating muscle conditions.
- This work bridges fundamental research in cell biology with potential clinical applications for age-related muscle decline.
More Related Videos
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
8.5K
09:32Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach
Published on: January 8, 2017
10.8K
Related Concept Videos
01:23Tissue Renewal without Stem Cells
2.1K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
2.1K
01:19The Effect of Aging on Tissues
3.4K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
3.4K
01:29Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
01:12Renewal of Skin Epidermal Stem Cells
3.0K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.0K
02:15Replicative Cell Senescence
4.3K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.3K
01:21Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K